Component

Collagen-induced human platelet aggregation

Species, preparation, dose and limitations are retained on linked claims.

1 recorded relationships. Experimental role, claim status and evidence remain attached to each record.

How nutrients influence it

Every nutrient with a recorded effect on this component, credited to the nutrient that acted rather than the chapter that recorded it. Open a nutrient to see the findings and the conditions they were measured under.

How nutrients reach it in more than one step

Chains of two or more recorded steps that end here, grouped by the nutrient they start from. Each step is a separate finding, so a chain is a route a mechanism could take, not proof that it does.

Tracing routes…

What it does

Every recorded relationship this component is part of, grouped by its role. Plain wording comes first; the technical statement follows.

Recorded relationships

What acts on it

  1. Hericenone B inhibited collagen-induced aggregation in washed rabbit and human platelets but did not inhibit aggregation induced by U46619, ADP, thrombin, adrenaline, arachidonic acid or convulxin.

    Experimental context and source evidence
    dose
    Purified hericenone B with multiple agonists
    duration
    Acute
    evidence_access
    Primary PubMed abstract and indexed metadata reviewed. Full-text method details not stated here remain unresolved.
    evidence_scope
    literature_reviewed; model-specific source-derived curation
    experimental_model
    Washed rabbit and human platelets
    limitations
    The proposed integrin-alpha2/beta1-to-arachidonate step was not a human oral antithrombotic trial.
    nutrient_topic
    Hericenones & Erinacines chapter; interacting nutrients, drugs, peptides and proteins retain their experimental settings. · Hericenones and erinacines
    organism
    Washed rabbit and human platelets
    plain_language
    Hericenone B inhibited collagen-induced aggregation in washed rabbit and human platelets but did not inhibit aggregation induced by U46619, ADP, thrombin, adrenaline, arachidonic acid or convulxin.
    primary_references
    Inhibitory effect of hericenone B from Hericium erinaceus on collagen-induced platelet aggregation. (2010). https://pubmed.ncbi.nlm.nih.gov/20637576/ DOI: 10.1016/j.phymed.2010.05.004
    route
    In vitro
    tissue
    Agonist-specific platelet aggregation

    Hericenones & Erinacines: mechanism of action and interactions (2026-09-20) · lines 55–64

    Original AI-assisted source-specific curation with primary-study citations, model, exposure, route, duration, negative findings and limitations preserved. Not publisher full text. · supports · Washed rabbit and human platelets · source_derived_draft · unverified_draft

    ## hericenones-erinacines-hericenone-b-platelets Hericenone B inhibited collagen-induced aggregation in washed rabbit and human platelets but did not inhibit aggregation induced by U46619, ADP, thrombin, adrenaline, arachidonic acid or convulxin. Model/species: Washed rabbit and human platelets Tissue/system: Agonist-specific platelet aggregation Exposure: Purified hericenone B with multiple agonists Route: In vitro Duration: Acute Limits: The proposed integrin-alpha2/beta1-to-arachidonate step was not a human oral antithrombotic trial. Primary reference: Inhibitory effect of hericenone B from Hericium erinaceus on collagen-induced platelet aggregation. (2010). https://pubmed.ncbi.nlm.nih.gov/20637576/ DOI: 10.1016/j.phymed.2010.05.004 Access: Primary PubMed abstract and indexed metadata reviewed. Full-text method details not stated here remain unresolved.
    Complete structured claim and evidence

In the sources

Preserved passages that mention this component, quoted exactly. Open one to read it in context.

    This is a research prototype built from draft material. It is not medical advice, and its statements still await verification against the original studies.

    Evidence, AI assistance and curation standards